Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,438 | 35,902 | 41,100 | 44,048 | 38,548 |
| Marketable Securities | 9,987 | N/A | N/A | N/A | N/A |
| TOTAL | $30,747 | $36,271 | $41,511 | $44,594 | $38,846 |
| Non-Current Assets | |||||
| PPE Net | 30 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 407 | 437 | 486 | 534 | 874 |
| TOTAL | $437 | $437 | $486 | $534 | $874 |
| Total Assets | $31,184 | $36,708 | $41,997 | $45,128 | $39,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,006 | 1,342 | 1,153 | 1,191 | 698 |
| Accrued Expenses | 3,294 | 2,418 | 2,026 | 1,102 | 815 |
| TOTAL | $6,300 | $3,760 | $3,179 | $2,293 | $1,513 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,300 | $3,760 | $3,179 | $2,293 | $1,513 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,451 | 842 | 840 | 840 | 814 |
| Common Shares | 21 | 21 | 21 | 21 | 15 |
| Retained earnings | -102,693 | -93,797 | -87,044 | -82,167 | -78,767 |
| Other shareholders' equity | 1 | 0 | 0 | 0 | 0 |
| TOTAL | $24,884 | $32,948 | $38,818 | $42,835 | $38,207 |
| Total Liabilities And Equity | $31,184 | $36,708 | $41,997 | $45,128 | $39,720 |